Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Dec 04 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report from the USFDA for its injectable facility in Jarod. The report classifies the facility as Voluntary Action Indicated following a GMP follow-up inspection conducted earlier. This disclosure is made in accordance with regulatory requirements for transparency to investors and exchange members.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases